Using of 6% hydroxyethyl starch 130/0.42 in term neonates during acute period of hie.
Introduction Objective of the study is to determine the efficacy of 6% hydroxyethyl starch (HES) 130/0.42 in a balanced crys- talloid solution in term neonates with severe hypoxic-is- chemic encephalopathy. Material and methods Single-center, prospective, simple, randomized con- trolled study was...
Main Author: | D. Surkov |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Anesthesia and Critical Care Journal
2019-01-01
|
Series: | Pediatric Anesthesia and Critical Care Journal (PACCJ) |
Subjects: | |
Online Access: | http://www.anestesiarianimazione.com/PACCJ%202019/Using%20of%20hydroxyethyl%20starch%20in%20term%20neonates%20%20during%20acute%20period%20of%20hie%20.pdf |
Similar Items
-
Mortality after hydroxyethyl starch 130/0.4 infusion: an updated meta-analysis of randomized trials
by: Christian Josef Wiedermann, et al.
Published: (2012-07-01) -
Outcomes and survival of neonates with Hypoxic Ischemic Encephalopathy (HIE) in a university hospital in Bushehr port 1999-2006
by: Gisoo Hatami, et al.
Published: (2006-09-01) -
Sources of Heterogeneity in Trials Reporting Hydroxyethyl Starch 130/0.4 or 0.42 Associated Excess Mortality in Septic Patients
by: Peng-Lin Ma, et al.
Published: (2015-09-01) -
Low-quality Trials as a Source of Heterogeneity in the Association of Hydroxyethyl Starch 130/0.4 or 0.42 with Excess Mortality in Sepsis
by: Christian J Wiedermann
Published: (2016-01-01) -
The role of G-CSF neuroprotective effects in neonatal hypoxic-ischemic encephalopathy (HIE): current status
by: John Sieh Dumbuya, et al.
Published: (2021-02-01)